Leo International Precision Health AG
Leo International Precision Health AG operates in the financial services sector, focusing on investment management and fund operations.
Business. Leo International Precision Health AG (LEOW.F) is an investment management and fund operator headquartered in Switzerland. The company operates within the Banking & Investment Services industry, generating revenue primarily through fee-based models. It is listed on the Frankfurt Stock Exchange under the ticker LEOW.F. Specific details regarding operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Leo International Precision Health AG (LEOW.F) is an investment management and fund operator headquartered in Switzerland. The company operates within the Banking & Investment Services industry, generating revenue primarily through fee-based models. It is listed on the Frankfurt Stock Exchange under the ticker LEOW.F. Specific details regarding operating segments and geographic revenue mix are not available.
- The company has no immediate dilution pressure based on current share counts.
- Liquidity risk cannot be assessed due to missing balance-sheet data and lack of going-concern language.
- Profitability and returns are indeterminate without access to financial metrics.
- Growth trajectory and segment exposure are not disclosed in the available data.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Leo International Precision Health AG Market data — financials · 2026-05-28
Ownership & reference
Leadership
- Axel KochChairman of the Supervisory Board